Introduction
Adherence to treatment does not refer simply to the act of taking the medications; rather, it refers to how the person manages their treatment in relation to doses, times, frequency and duration (1) . In the context of chronic illnesses, in which the people and their relatives are responsible for the greater part of the care, adherence must be seen as a joint activity in which the person not only follows medical advice, but understands, agrees with and adopts the regimen described (2) .
Among the chronic non-transmissable diseases which are responsible for chronic health conditions, Diabetes Mellitus (DM) stands out, because of its epidemic proportions on the national (3) (4) and global scale (5) , and the concept of adherence, for this disease, includes, as well as drug therapy, an individualized nutritional plan, regular physical exercise, and general care (6) . Non-adherence to the therapeutic regimen contributes to poor metabolic control, resulting in acute and long-term complications (7) .
Drug treatment for DM is complex and can involve different drugs with multiple dosages, as well as daily administration of exogenous insulin (6) . The rates of adherence, in general, vary from 31% to 98% (8) (9) (10) (11) (12) , and there is evidence that the more complex the therapeutic regimen, the lesser the adherence (7) . In this regard, the literature has shown that adherence to the use of insulin is lower than adherence to the use of oral antidiabetics (OADs), with rates between 36% and 80% and from 46.4% to 86%, respectively (7, (13) (14) (15) . This also suggests that adherence behaviors may not be related to each other, that is, people can adhere to one aspect of the treatment, but not to the other (7) .
Another question which is relevant to adherence to treatment is how to measure it. It is difficult to determine an acceptable measurement of adherence due to this being a multi-dimensional concept, which can, moreover, be calculated by different methods, each with its advantages and limitations (16) . The method used most for assessing adherence to treatment has been structured questionnaires, due to their simplicity and low cost, the fact that one obtains results immediately, and the possibility of detecting approximately 50% of people who do not adhere to the treatment regimen (1) .
In Brazil, studies aiming to evaluate adherence to drug treatment for DM (9, 12) and other chronic illnesses( 17) have used the Measurement of Adherence to Treatments (MAT) questionnaire (18) , an instrument which is accessible and easy to administer. Because this questionnaire was not developed exclusively for people with DM, however, it does not specifically cover adherence to OADs and insulin. Furthermore, instruments were not identified in the literature specifically evaluating these two aspects of the treatment.
Therefore, the present study aimed to verify the face validity and criterion-related validity, and the reliability of the MAT instrument, presented in two forms referent to the evaluation of adherence to the use of OADs and insulin, distinctly, and to assess whether there are differences in the scores for adherence between these two modes of drug therapy.
Method
This is a cross-sectional and methodological study, (19) .
People were invited to participate in the study verbally, in the waiting room, while they waited to be seen. After the presentation of the study's objectives, Gomes-Villas Boas LC, Lima MLSAP, Pace AE.
and clarifications on the anonymity of participation, the people were asked to indicate whether they agreed or not to participate in the study. Those who agreed were taken to a room set aside for data collection. The first item to be handed over was the Terms of Free and Informed Consent, which was read out loud by one of the researchers. Once it had been read, the participant was requested to sign it.
For the collection of socio-demographic and clinical data, a semi-structured instrument was used, developed based on a previous study (12) . The data referent to adherence to drug treatment was collected using the questionnaire Measurement of Adherence to Treatment (MAT) (18) . This instrument had been adapted and validated in Portugal, with good internal consistency (Cronbach alpha coefficient of 0.74) (18) , and was adapted for Brazilian Portuguese (9, 12) . The MAT is a scale made up of seven items and is for evaluating adherence to prescribed treatment with medications. All the items present a response pattern which goes from "always" to "never", with scores varying, respectively, from one to six.
The adherence is determined by the instrument's global mean, that is, the scores for each item are summed and divided by the number of items (seven). Higher means indicate greater adherence to the treatment (18) .
A previous study (12) using the MAT, in a sample of 162 people with DM2 under outpatient treatment, showed that the instrument has acceptable reliability (Cronbach alpha of 0.66), according to a review study on the analysis of the psychometric properties of instruments for evaluating subjective phenomena, which considered values over 0.50 as reasonable (20) .
Following the authors' agreement (18) , for the present study, this instrument's questions relating to the modes of treatment were reviewed, giving rise to two ways of presenting the MAT; that is, one for evaluating the adherence to the drug therapy with OADs, and another, with insulin, respectively titled "Measurement of Adherence to Drug Therapy in Diabetes MellitusOral Antidiabetics" (MAT OADs) and "Measurement of Adherence to Drug Therapy in Diabetes Mellitus -Insulin Therapy" (MAT insulin).
In the MAT OADs, the word "medications " was substituted with "tablets" in all the items, apart from item 5 ("Have you taken one or more tablets for diabetes, on your own initiative, because of feeling worse?"), which did not need changing, remaining identical to how it was in the original version. It is believed that the use of the word "tablets", in all the items, may reflect a better standardization of the same.
Similarly, in the MAT insulin, the expression "take the medications" in items 1, 3, 4 and 7 was substituted with the expression "administer the insulin"; in item 2, the expression "time for taking the medications" was substituted with "time to administer the insulin"; in item 5, "taken one or more tablets" was substituted with "administered one or more units of insulin"; and in item 6, the expression "have let your medications run out"
was substituted with "have let your insulin run out".
It should be emphasized that no other term of the items was altered, so as to maintain the similarity with the original version, and not to de-characterise the instrument, given that it had been validated for the Portuguese language.
For the face validity (21) , the two forms of presentation of the MAT were submitted for approval by three health professionals who work in the area of care
for people with DM, and the evaluation of each item's relevance and clarity was requested. Following this, the researchers proceeded to the semantic analysis, the aim of which is to check if all the items are understandable for the target population (21) . It is recommended that the understanding of the items should be verified with few subjects. The items are presented one-by-one and the subjects are requested to re-phrase them. If this is done without doubts, the item is correctly understood.
Otherwise, the researcher must explain what is meant by the item in question, after which the respondents are requested to make suggestions such that the item may be reformulated (21) . In this way, the two forms of the presentation of the MAT were administered to five people with this illness.
For the criterion-related validity, the researchers These instruments' reliability was evaluated through three methods: calculation of the Cronbach alpha coefficient for analysis of internal consistency; the itemtotal correlation and the Pearson correlation co-efficient.
The strength of the correlations was ascertained in accordance with the following classification: weak (r<0.3), moderate (0.3<r<0.6) and strong (r>0.6) (22) .
The evaluation of the adherence was undertaken by measurements of central tendency (mean and median)
and of the variability (standard deviation) of the final
Results

Socio-demographic and clinical characterization, and treatment of the sample
In the socio-demographic characterization of the sample, the mean age and respective standard deviation 
ROC Curve
Diagonal segments are produced by ties.
MAT OADs
MAT insulin
Gomes-Villas Boas LC, Lima MLSAP, Pace AE.
In the reliability analysis, evaluated using the (Table 1) . Table 2) .
Items of the forms of Measurement of Adherence to Treatment (N = 90)
MAT OADs (α = 0.84) MAT insulin (α = 0.68)
Item-total correlation
Cronbach alpha if the item is removed
Item-total correlation
Cronbach alpha if the item is removed
1-Have you ever forgotten to take the tablets/ administer the insulin for the diabetes? In the analysis of the adherence, the item with the lowest mean in both forms of the instrument was item 2.
The highest means were for 5 (MAT OADs) and 7 (MAT insulin) (Table 3 ).
In undertaking the paired Student t-test, a statistically significant difference was found between the final scores of the two forms of the instrument,
indicating greater adherence to the use of the insulin than to the OADs. In comparing the means of the items of the MAT OADs with the MAT insulin, there were also statistically-significant differences in items 1, 4, 6 and 7 (Table 4) . 
Discussion
In relation to the socio-demographic characterization, the sample was made up of adults of low schooling and low incomes, retired, with a mean age of 60 years old, there being a majority of women (67.8%). These results are similar both to the original study in which the instrument was developed (18) , and to those in which this instrument was adapted for Brazil (9, 12, 17) .
In the criterion-related validity, the area under the curve was 0.83 and 0.77 for the MAT OADs and the MAT insulin, respectively. The area under the ROC curve is a measurement of the performance of a test, that is, it determines its exactitude. A test which is totally incapable of distinguishing adherent people and nonadherent people would have an area under the curve of 0.5, which corresponds to the null hypothesis. Areas over 0.70 are considered satisfactory (23) .
Regarding internal consistency, the Cronbach alpha values found were 0.84 and 0.68 for the MAT OADs and MAT insulin, respectively. Internal consistency is one of the ways of evaluating an instrument's reliability (24) , as it indicates the extent to which an instrument's items are homogeneous, that is, are inter-correlated, thus measuring the same concept. The Cronbach alpha is considered a good measurement of internal consistency.
Its value should vary from 0.70 to 0.95. This coefficient is sensitive to the instrument's number of items, and for this reason higher values are commonly found in instruments with a greater number of items (19) .
It may be observed that although the MAT instrument has only seven items, the value of the Cronbach alpha coefficient is found within an interval considered satisfactory by the literature (19) . For the MAT insulin, this coefficient had a value below 0.70;
however, according to the review study on analysis of the psychometric properties of instruments for assessing subjective phenomena, values over 0.50 are considered acceptable (20) . It may also be observed that the two forms proposed in the present study present
Cronbach alpha coefficients which are superior to those of the study of the adaptation of the MAT for the use of oral anticoagulants, where the value found was 0.60 (17) .
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When the alpha value was evaluated with the removal of each one of the items, a variation from 0.79 to 0.85 was obtained for the MAT OADs, and from 0.60 to 0.69 for the MAT insulin. In the original study in which the instrument (MAT original) was developed, the variation was from 0.69 to 0.73 (19) . The item-total correlation is another measurement of an instrument's reliability (24) . In the present study, the values of the item-total correlations varied from 0.38 to 0.77 for the MAT OADs and from 0.20 to 0.53 for the MAT insulin. It is desirable for the item-total correlation to be superior to 0.20. On the other hand, a high item-total correlation (> 0.80) can be indicative of redundancy (25) .
It may be observed that the item-total correlations were equal to or superior to 0.20, in the forms of presentation, suggesting that the administration of this instrument, separately, is reliable.
In the evaluation of the reliability using the Regarding adherence, the item with the lowest mean in both the forms of the instrument was item 2.
This result suggests that in regard to the use of both OADs and insulin, the majority of the participants show the least adherence in regard to the time of day at which they use these medications. The items with the highest means were 5 (MAT OADs) and 7 (MAT insulin). This data shows that, for the OADs, the majority of the participants present adherence to the dosage prescribed, and that in relation to insulin therapy, the majority do not interrupt the use of insulin unless told to do so by their doctor. OADs (73%; 86% respectively) (13) . The greater adherence to insulin than to OADs in the sample studied may be attributed to the long time that the people involved had DM, as well as to the presence of its complications. In addition to this, the risk of hypoglycemia, associated with the use of insulin (6) , can make the person administer the correct dose of this hormone.
When the means of the items between the two forms were compared, there were statistically significant differences in items 1, 4, 6 and 7, which shows greater adherence, in these items, for the MAT insulin.
These last results suggest that in dealing with the use of OADs associated with insulin, instruments should be used which evaluate the adherence to these modes of treatment separately, because a single instrument cannot capture these differences. It is possible that in the sample studied, had a single instrument been used, adherence to the OADs could have been overestimated, due to the fact of the adherence to insulin being higher.
Conclusion
The present study's results allow one to consider that the two instruments, derived from the original version of the MAT, present psychometric properties which characterize them as reliable.
The two forms of the presentation of the MAT made it possible to detect differences in adherence between the modes of drug treatment, showing there to be greater adherence to the insulin therapy than to the OADs -which might not be detected, were a single instrument to be used. It is therefore emphasized that for people with DM, separate instruments should be used to evaluate the adherence to treatment with OADs and to treatment with insulin.
Some weak points, however, deserve to be 
